February 25, 2026 - 17:14

Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company, has announced its participation in the upcoming 46th Annual TD Cowen Health Care Conference. The company's presentation is scheduled for Monday, March 2, 2026.
The conference is a key forum where leading healthcare companies connect with the investment community. Anavex's management is expected to provide a comprehensive overview of the company's development pipeline, which focuses on novel therapies for neurodegenerative and neurodevelopmental disorders, including Alzheimer's disease, Parkinson's disease, and Rett syndrome.
Investors and interested parties will have the opportunity to access a live audio webcast of the corporate presentation. This event allows for direct communication from company leadership regarding recent progress, clinical milestones, and the strategic direction of its research programs. The presentation will be closely watched by analysts and shareholders for updates on the company's lead drug candidate, blarcamesine, and its potential across multiple central nervous system conditions.
May 26, 2026 - 17:23
Dog daycare leptospirosis outbreak in Los Angeles reveals broader public health risksA 2021 outbreak of leptospirosis that sickened more than 200 dogs in Los Angeles County reveals critical gaps in vaccination practices and raises broader concerns about the spread of the disease...
May 26, 2026 - 08:30
Public Health Command Europe Hosts 71st International Military Veterinary ExchangePublic Health Command Europe recently welcomed nearly 100 veterinary leaders from 18 allied and partner nations for the 71st International Military Veterinary Exchange. The event focused on...
May 25, 2026 - 22:58
Vaya Health and Partners Health Management to merge on Oct. 1The North Carolina Department of Health and Human Services has given the green light for the merger of two major managed care organizations, Vaya Health and Partners Health Management. The...
May 25, 2026 - 12:02
The Overlooked Outcomes of the 79th World Health AssemblyFor the world`s second-leading cause of death and the third-leading cause of disability, stroke has spent decades waiting for its turn at the World Health Assembly. The 79th meeting in Geneva this...